Deepening Understanding of Complement Biology in Ophthalmology to Enable Targeted Intervention & Improve Patient Outcomes

• Investigating the role of complement dysregulation across ophthalmologic diseases and its contribution to disease onset, progression and vision loss
• Identifying biomarkers that could predict disease development, patient risk and treatment response to support earlier intervention strategies
• Elucidating relevant targets within the complement cascade that offer the greatest therapeutic potential within ocular diseases

Speakers:

Stephen Poor

Head, Translational Medicine

Apellis Pharmaceuticals